SPG Block are often considered Miracle Treatments for Migraines and other chronic pains. The Book “Miracles on Park Avenue” was published in the late 1980’s and Dr Shapira learned the technique shortly after by his friend Dr Jack Haden. Dr Shapira later learned several other methods of utilizing the SPG Block from Dr Larry Lockerman, Dr Barry Glassman, Dr Lawrence Robbins, Dr Brendan Stack. He also trained with TX360 and Spenocath techniques.
Dr Shapira is one of very few doctors around the world who teaches patients to self administer Sphennopalatine Ganglion Blocks. He is currently working on Patents which will vastly improve the range of treatments that can be directed toward this autonomic ganglion.
The following was originally published at NorthShoreSleepDentist.com
PATIENTS WHO ARE INTERESTED IN EXPERIENCING SPHENOPALATINE GANGLION BLOCKS AND LEARNING HOW TO SELF ADMINISTER THE BLOCKS CAN CONTACT DR SHAPIRA THRU HIS WEBSITE.
TREATMENT OF CHRONIC MIGRAINES, TENSION HEADACHES AND AUTONOMIC CEPHALGIAS AS WELL AS OTHER CHRONIC PAIN CONDITIONS CAN BE IMPROVEd WITH UTILIZATION OF SPHENOPALATINE GANGLION BLOCKS.
There are several testimonials on SPG Blocks at ICCMO:
WHERE DO YOU LEARN TO ADMINISTER SPG BLOCKS? Dr Shapira now offers classes in Highland Park!
It is well established that the Sphenopalatine Ganglion Block is one of the most effective treatments for preventing migraine and chronic daily headaches available but it is often difficult to learn the procedures. I teach Sphenopalatine Ganglion Administration in my Highland Park, Illinois office to doctors want to incorporate this into their practice and to patients wanting to learn self administration of SPG Blocks.
I teach a variety of trigger point injection techniques in the jaw, head, neck and shoulder regions to both dentists and physicians. I invite doctors to bring their patients with them to the course. The primary area of interest of many doctors is learning to do the Sphenopalatine Ganglion Blocks. I teach doctors several methods of administering SPG Blocks. Doctors are invited to bring their team and their patients to the course as well.
The Sphenopalatine Ganglion Block was made popular in the late 1980’s by the book “Miracles on Park Avenue”. I strongly suggest that patients with chronic pain, migraines, tension headaches or TMJ Disorders read this book.
The Spenopalatine Ganglion, also called Meckels Ganglion, the Nasal Ganglion or the Pterygopalatine Ganglion is the largest of four Parasympathetic Ganglions in the head and neck and has both sympathetic and parasympathetic fibers running throught it. It is found in the Pterygopalatine fosa. The SPG is associated with the branches of the maxillary nerve,one of the three major branches of the Trigeminal Nerve.
The SPG supplies the lacrimal gland, paranasal sinuses, glands of the mucosa of the nasal cavity and pharynx, the gingiva, and the mucous membrane and glands of the hard palate. It communicates anteriorly with the nasopalatine nerve, also part of the Trigeminal Nerve. The SPG receives a sensory, a parasympathetic, and a sympathetic root.
The sensory root of the Sphenopalatine Ganglion comes from two sphenopalatine branches of the maxillary division of the Trigeminal Nerve and the fibers pass into the palatine nerves.
The Parasympathetic root is derived from the nervus intermedius a branch of the facial nerve.
The SphenoPalatine Ganglion also carries fibers from the superior cervical ganglion, SCG. These are sympathetic efferent (postganglionic) fibers from the SCG that travel through the carotid plexus and then through the deep petrosal nerve, which joins with the greater petsal nerve to form the pterygoid canal nerve.
Learnig to work with SphenoPalatine Ganglion blocks will allow practitiones to handle difficult cases that were often resistant to treatment because of their autonomic components. All classes are by by appointment. I will teach individual doctors or small groups.
SPG Nerve Block catheter Bibliography
CHRONIC DAILY HEADACHE AND MIGRAINE
Agency of Healthcare Research and Quality, a division of the Department of Health &
Human Services, “Over 3 Million Look to Hospitals for Headache Relief,
Particularly for Migraines,” http://www.ahrq.gov/news/nn/nn050411.htm
Archibald N, et al. Resource Utilization and Costs of Care for Treatment of Chronic
Headache. Rockville (MD): Agency for Health Care Policy and Research (US);
February 1999, http://www.ncbi.nlm.nih.gov/books/NBK45258/
Castillo, J, et al. Epidemiology of Chronic Daily Head in the General Population,
Headache, March 1999, http://www.ncbi.nlm.nih.gov/pubmed/15613213
CIA World Fact Book, https://www.cia.gov/library/publications/the-worldfactbook/
Coeytaux, RR, et al. Chronic daily headache in a primary care population: prevalence
and headache impact test scores. Headache. 2007 Jan; 47(1): 7-12,
Cohen, S, et al. A new interest in an old remedy for headache and backache for our
obstetric patients: a sphenopalatine ganglion block. Anaesthesia, 2000, 56, 606-
Evans, RW, Diagnostic Testing for Chronic Daily Headache, Current Pain and
Headache Reports 2007, 11:47-52,
Garza, I, et al. Diagnosis and Management of Chronic Daily Headache. Semin Neurol
2010; 30(2): 154-166, http://www.medscape.com/viewarticle/723842
Halker, RB, et al. Chronic Daily Headache: An Evidence-Based and Systemic
to a Challenging Problem. Neurology Clinical Practice 2011:76 (Suppl 2): S37-
Hu, XH, et al. Burden of Migraine in the United States. Arch Intern Med. Vol. 159,
Apr. 26, 1999, http://archinte.ama-assn.org/cgi/content/abstract/159/8/813
In office surgical fee schedule at
Lafata, JE, et al. The medical Care Utilization and Costs Associated with Migraine
Headache. J Gen Intern Med. 2004 October; 19(10): 1005-1012,
Lucado, J, et al. Headaches in U.S. Hospitals and Emergency Departments, 2008.
Statistical Brief #111, published May 2011, Healthcare Cost and Utilization
Machlin, S., and Chowdhury, S., “Expenses and Characteristics of Physician Visits in
Different Ambulatory Care Settings, 2008.” Statistical Brief #318. March 2011.
Agency for Healthcare Research and Quality, Rockville, MD,
Munakata, J, et al. Economic burden of transformed migraine: results from the
Migraine Prevalence and Prevention (AMPP) Study. Headache 2009 Apr; 49(4):
Natoli, JL, et al. Global Prevalence of Chronic Migraine: A Systematic Review.
Cephalalgia, May 2009,
Ramirez-Lassepas M, et al. Predictors of intracranial pathologic findings in patients
who seek emergency care because of headache. Arch Neurol. 1997 Dec; 54(12):
Silberstein, SD, et al. “Chronic Daily Headache,” 2012, at
Silberstein, SD. Chronic Daily Headache: Classification, Epidemiology, And Risk
Factors. Johns Hopkins Advanced Studies in Medicine, October 2006,
TRIGEMINAL NERVE BLOCK
Cohen, S, et al. Sphenopalatine ganglion block for postdural puncture headache.
Anaesthesia, 2009, 64, 574.
Dodick, DW. Chronic Daily Headache. N Engl J Med 12 Jan. 2006; 354:158-65,
Harrison, Pam. Stellate Ganglion Blockade Shows Promise as Effective, Durable
Treatment for PTSD. http://www.medscape.com/viewarticle/721079
Peterson, JN, et al. Sphenopalatine ganglion block: a safe and easy method for the
management of orofacial pain. Cranio The Journal Of Craniomandibular
Practice. 1995, Volume: 13, Issue: 3, Pages: 177-181,
Quevedo, JP, et al. Complex Regional Pain Syndrome Involving the Lower Extremity:
Report of 2 cases of Sphenopalatine Block as a Treatment Option. Arch Phys
Med Rehabil. 2005 Feb; 86(2): 335-37,
Reder, M. “Conditions Treated with SGB,”
Saberski, L, et al. Sphenopalatine ganglion block for treatment of sinus arrest in
postherpetic neuralgia. Headache. 1999 Jan; 39(1): 42-4,
Sluder G. The role of the sphenopalatine ganglion in nasal headaches. N Y State J
1908: 27: 8-13.
Washington State Hospital Association, “Washington State Hospital Association
Emergency Room Use,” review of 2,631,071 ED visits over an 18-month period
with 42,816 visits for headaches, http://www.wsha.org/files/127/ERreport.pdf
Kanai, A, et al. Intranasal lidocaine 8% spray for second-division trigeminal neuralgia.
Br J Anaesth. 2006 Oct; 97(4): 559-63,
Kudrow L, et al. Rapid and sustained relief of migraine attacks with intranasal
preliminary findings. Headache. 1995 Feb; 35(2): 79-82,
Maizels, M, et al. Intranasal Lidocaine for Treatment of Migraine: A Randomized,
Double-blind, Controlled Trial. JAMA, July 24/31, 1996—Vol. 276, No. 4,
Rosen, N. Effect of Lidocaine Infusion in the Treatment of Refractory Chronic Daily
Headache – A Retrospective Study. Poster P04.099. Reported by Jill Stein at
Williams, D, et al. Intravenous lignocaine (lidocaine) infusion for the treatment of
chronic daily headache with substantial medication overuse. Cephalalgia, 23
(December 2003): 963-971, http://www.ncbi.nlm.nih.gov/pubmed/14984229
World Health Organization (WHO) website,
#SPB, #SPGBLOCK, #SPHENOPALATINEGANGLIONBLOCK, #meckel’sganglion, #pterygopalatineganglion, #autonomicblocks, #parasympathetic , #parasympatheticblocks, #adrenylsyndrome, #SPGBlockMigraine, #SPGBlockChronicDailyHeadache, #WheretolearnSPGBlocks, #WhodoesSPGBlocks ##Wheretolearnsphenopalatineganglionblocks,